GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Eton Pharmaceuticals, Inc. - Common Stock (ETON)

Symbol: ETON on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$9,557,084	565,051	-8,979	-1.6%	$16.91	Q4 2025
30 Sep 2025	0%	-0%	$12,476,472	574,030	-18,835	-3.2%	$21.73	Q3 2025
30 Jun 2025	0%	+0%	$8,450,021	592,865	+294,617	+99%	$14.25	Q2 2025
31 Mar 2025	0%	+0%	$3,873,133	298,248	+29,602		$12.99	Q1 2025
31 Dec 2024	0%	-0%	$3,580,281	268,646	-4,050	-1.5%	$13.33	Q4 2024
30 Sep 2024	0%	+0%	$1,636,518	272,696	+32,365	+13%	$6.00	Q3 2024
30 Jun 2024	0%	+0%	$790,884	240,331	+6,164	+2.6%	$3.29	Q2 2024
31 Mar 2024	0%	+0%	$878,341	234,167	+6,911	+3%	$3.75	Q1 2024
31 Dec 2023	0%	+0%	$995,611	227,256	+9,627	+4.4%	$4.38	Q4 2023
30 Sep 2023	0%	+0%	$907,754	217,629	+7,537	+3.6%	$4.17	Q3 2023
30 Jun 2023	0%	+0%	$733,221	210,092	+23,510	+13%	$3.49	Q2 2023
31 Mar 2023	0%	0%	$718,340	186,582	0		$3.85	Q1 2023
31 Dec 2022	0%	0%	$522,000	186,582	-389	-0.21%	$2.80	Q4 2022
30 Sep 2022	0%	0%	$392,000	186,971	0		$2.10	Q3 2022
30 Jun 2022	0%	0%	$489,000	186,971	0		$2.62	Q2 2022
31 Mar 2022	0%	+0%	$815,000	186,971	+11,118	+6.3%	$4.36	Q1 2022
31 Dec 2021	0%	+0%	$754,000	175,853	+18,737	+12%	$4.29	Q4 2021
30 Sep 2021	0%	+0%	$791,000	157,116	+1,835	+1.2%	$5.03	Q3 2021
30 Jun 2021	0%	-0%	$956,000	155,281	-110,264	-42%	$6.16	Q2 2021
31 Mar 2021	0%	+0%	$1,943,000	265,545	+49,506	+23%	$7.32	Q1 2021
31 Dec 2020	0%	+0%	$1,756,000	216,039	+68,212	+46%	$8.13	Q4 2020
30 Sep 2020	0%	+0%	$1,167,000	147,827	+41,815	+39%	$7.89	Q3 2020
30 Jun 2020	0%	+0%	$577,000	106,012	+106,012	NEW	$5.44	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.